Key stats
About Guotai CSI Medical Service Exchange Traded Fund Units
Home page
Inception date
Dec 24, 2020
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Guotai Asset Management Co., Ltd.
ISIN
CNE100005S04
Closely track underlying index,Tightly track the target and minimize the deviation.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.65%
Health Technology74.85%
Health Services14.12%
Process Industries5.89%
Distribution Services1.65%
Technology Services1.63%
Producer Manufacturing0.86%
Commercial Services0.38%
Consumer Non-Durables0.28%
Bonds, Cash & Other0.35%
Cash0.35%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159828 invests in stocks. The fund's major sectors are Health Technology, with 74.85% stocks, and Health Services, with 14.12% of the basket. The assets are mostly located in the Asia region.
159828 top holdings are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A and WuXi AppTec Co., Ltd. Class A, occupying 10.61% and 9.97% of the portfolio correspondingly.
159828 assets under management is 2.02 B CNY. It's fallen 4.23% over the last month.
159828 fund flows account for −539.18 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159828 doesn't pay dividends to its holders.
159828 shares are issued by Guotai Asset Management Co., Ltd. under the brand Guotai. The ETF was launched on Dec 24, 2020, and its management style is Passive.
159828 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159828 follows the CSI Medical Index Yield - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159828 invests in stocks.
159828 price has risen by 2.97% over the last month, and its yearly performance shows a 14.39% increase. See more dynamics on 159828 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.79% over the last month, have fallen by −0.79% over the last month, showed a 16.16% increase in three-month performance and has increased by 19.76% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −0.79% over the last month, have fallen by −0.79% over the last month, showed a 16.16% increase in three-month performance and has increased by 19.76% in a year.
159828 trades at a premium (0.17%) meaning the ETF is trading at a higher price than the calculated NAV.